Chemotherapy dose standardisation: Key therapeutic topic [KTT22]
This document summarises the evidence-base on chemotherapy dose standardisation. It is a key therapeutic topic which has been identified to support medicines optimisation. It is not formal NICE guidance.
https://www.nice.org.uk/advice/ktt22
Thanks to all the BOPA members who have contributed to the implementation support documents.
This article is brought to you as part of a collaboration with the Pharmaceutical Journal (PJ). The views expressed in this article are those of the author and are not…
The popular Introduction to Cancer Course is coming to London in September 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 17th & Friday 18th September 2026 WHERE: University College Hospital,…
Dear BOPA members, The Cancer Information Development team at Macmillan Cancer Support would like to make you aware of a couple of new cancer treatment information pages on our website:…
Bespoke CPD Course on Health Technology Assessment (HTA) We are delighted to see the launch of the BOPA Health Technology Assessment (HTA) course, which represents an important step forward in supporting the cancer pharmacy workforce…
The 29th BOPA Annual Conference in 2026 will be held at the ICC London Olympia on 2-4 October 2026.
Check out the latest information here: Latest Conference 2026 – BOPA
Everything you need to know
